Clinical Trial

12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Perimenopause is a transition phase into menopause, characterised by menopausal symptoms while menstrual periods are still occurring. Common symptoms of perimenopause include hot flushes, night sweats, mood swings, anxiety, sleep disturbances, fatigue, and cognitive difficulties. These symptoms can be both frequent and intense, with the potential to significantly deteriorate women's quality of life. Despite an increase in public discourse around menopause, there are still large gaps in knowledge. Previous literature has suggested a relationship between diet and menopause management. However, studies in this area are limited and women often rely on social media for advice on supplements to address menopause complaints. One supplement that has received a lot of attention with purported benefits for menopause is magnesium, primarily due to its links to energy and or/sleep, however no studies have explored psychological effects of magnesium supplementation in perimenopause. The aim of this study is to explore the effects of 12-weeks magnesium supplementation on perimenopause symptoms, cognition, sleep, and psychological well-being.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-06
notable Primary completion pushed: 2026-08-01 -> 2026-10-18 2026-08-06
minor Completion pushed: 2026-08-01 -> 2026-12-01 2026-08-06
Trial Details
NCT Number NCT07235878
Lead Sponsor Northumbria University
Collaborators: Vitabiotics
Conditions Perimenopause, Perimenopausal Women, Perimenopause, Climacteric Syndrome
Enrollment 58 participants
Start Date 2025-12-09
Primary Completion 2026-10-18 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-05